Get Level 2

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. GHS.L Share Price
  4. GHS.L Share Regulatory News
  5. Board Change

Pin to quick picksGHS.L Regulatory News (GHS)

GHS.L Information
  • There is currently no data for GHS

Board Change

12 Dec 2013 07:00

RNS Number : 3204V
Spark Ventures PLC
12 December 2013
 

SPARK Ventures plc

("SPARK" or the "Company")

 

Board change

 

 

SPARK Ventures announces that with immediate effect, Michael Whitaker is no longer a director of the Company.

 

David Potter, Chairman said, "We are grateful to Mike for the contribution he has made to the Company since its formation."

 

 

For further information, please contact:

 

SPARK Ventures plc

David Potter (Chairman)

Andrew Betton (Secretary)

 

 

020 7851 7777

finnCap

Matt Goode /

Christopher Raggett

 

020 7220 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATBBFTMBMBBTJ
12345678910
Date   Source Headline
23rd Mar 20207:00 amRNSTransaction in Own Shares / Total Voting Rights
16th Mar 20201:42 pmRNSNAV Update
16th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20201:00 pmRNSNAV Update
6th Mar 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
2nd Mar 202012:49 pmRNSMonthly NAV Update
28th Feb 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
24th Feb 20202:07 pmRNSNAV Update
21st Feb 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
17th Feb 20202:44 pmRNSNAV Update
14th Feb 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
10th Feb 20202:19 pmRNSNAV Update
3rd Feb 202012:47 pmRNSMonthly NAV Update
31st Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
27th Jan 202012:52 pmRNSNAV Update
24th Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Jan 20207:00 amRNSQuarterly Factsheet
20th Jan 20202:26 pmRNSNAV Update
17th Jan 20206:26 pmRNSHolding(s) in Company
17th Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
13th Jan 202012:23 pmRNSNAV Update
10th Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
7th Jan 20203:24 pmRNSDirector/PDMR Shareholding
6th Jan 20201:34 pmRNSNAV Update
3rd Jan 20205:42 pmRNSTransaction in Own Shares / Total Voting Rights
2nd Jan 202012:35 pmRNSMonthly NAV Update
23rd Dec 20194:19 pmRNSHolding(s) in Company
23rd Dec 201911:56 amRNSNAV Update
20th Dec 20195:29 pmRNSTransaction in Own Shares / Total Voting Rights
20th Dec 20197:00 amRNSAppointment of corporate broker
19th Dec 20194:00 pmRNSHolding(s) in Company
19th Dec 20193:55 pmRNSHolding(s) in Company
19th Dec 20193:50 pmRNSHolding(s) in Company
16th Dec 20191:19 pmRNSNAV Update
13th Dec 20196:30 pmRNSTransaction in Own Shares / Total Voting Rights
9th Dec 20191:48 pmRNSNAV Update
2nd Dec 20191:27 pmRNSMonthly NAV Update
29th Nov 20196:15 pmRNSTransaction in Own Shares / Total Voting Rights
26th Nov 20196:30 pmRNSHolding(s) in Company
26th Nov 20197:00 amRNSInterim Results
25th Nov 201912:24 pmRNSNAV Update
22nd Nov 20196:00 pmRNSTransaction in Own Shares / Total Voting Rights
19th Nov 20194:04 pmRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20192:48 pmRNSNAV Update
15th Nov 20195:30 pmRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20191:36 pmRNSNAV Update
8th Nov 20196:00 pmRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20191:55 pmRNSNAV Update
1st Nov 20195:40 pmRNSTransaction in Own Shares & Total Voting Rights
1st Nov 201912:04 pmRNSMonthly NAV Update
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CLLN
Carillion Plc
LSE
0.00%
ELM
Elementis
LSE
1.01%
PAR
PAR.L
LSE
0.00%
FOXT
Foxtons
LSE
4.38%
ICP
ICP.L
LSE
0.00%
Trending
IMM
Immupharma
LSE
4.35%